Biofil Chemicals & Pharmaceuticals

quarterly
yearly
ParticularsDec '23Mar '24Jun '24Sep '24Dec '24
Revenue5.0615.618.472.4314.22
Expenses4.9515.338.242.4014.00
EBITDA0.220.380.340.140.33
EBIT0.110.290.240.040.23
Profit Before Tax0.110.280.230.030.22
Net Profit0.090.250.170.020.16
Financial Ratios
Operating Profit Margin4.37%2.43%4.03%5.81%2.32%
Net Profit Margin1.79%1.64%2.01%0.83%1.13%
Earning Per Share (Diluted)0.060.150.100.010.10
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ